{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T15:13:27Z","timestamp":1781104407541,"version":"3.54.1"},"reference-count":48,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2019,7,30]],"date-time":"2019-07-30T00:00:00Z","timestamp":1564444800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Mississippi Evidence-Based DUR Initiative"},{"name":"Center for Pharmaceutical Marketing and Management"},{"name":"Mississippi Division of Medicaid"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>The association of historical opioid use with health care use and death among patients with chronic obstructive pulmonary disease (COPD) has been tested. Using Mississippi Medicaid data, we examined the association of transient or short-term opioid use and acute respiratory exacerbations among adults with COPD. We used a case-crossover design and 2013\u20132017 Mississippi Medicaid administrative claims data. A total of 1,972 qualifying exacerbation events occurred in 1,354 beneficiaries. The frequency and dose of opioid exposure in the 7 days before the exacerbation were examined and compared with the opioid exposure in 10 control windows, each 7 days long, before the exacerbation. Adjusted odds ratios were estimated using conditional logistic regression models to estimate the risk of opioid use on exacerbations after accounting for use of bronchodilators, corticosteroids, benzodiazepines, and \u03b2-blockers. Overall, opioid exposure in the 7 days before an exacerbation was significantly associated with acute respiratory exacerbation (odds ratio = 1.81; 95% confidence interval: 1.60, 2.05). Each 25-mg increase in morphine equivalent daily dose was associated with an 11.2% increase in the odds of an acute respiratory exacerbation (odds ratio = 1.11; 95% confidence interval: 1.04, 1.20). Transient use of opioids was significantly associated with acute respiratory exacerbation of COPD.<\/jats:p>","DOI":"10.1093\/aje\/kwz169","type":"journal-article","created":{"date-parts":[[2019,7,18]],"date-time":"2019-07-18T19:18:43Z","timestamp":1563477523000},"page":"1970-1976","source":"Crossref","is-referenced-by-count":8,"title":["Association Between Transient Opioid Use and Short-Term Respiratory Exacerbation Among Adults With Chronic Obstructive Pulmonary Disease: A Case-Crossover Study"],"prefix":"10.1093","volume":"188","author":[{"given":"Yiran","family":"Rong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John P","family":"Bentley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald","family":"McGwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin F","family":"Banahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara L","family":"Noble","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terri","family":"Kirby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujith","family":"Ramachandran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,8,30]]},"reference":[{"key":"2019110318561829600_kwz169C1","author":"Heron","year":"2019"},{"issue":"11","key":"2019110318561829600_kwz169C2","first-page":"290","article-title":"Employment and activity limitations among adults with chronic obstructive pulmonary disease \u2013 United States, 2013","volume":"64","author":"Wheaton","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2019110318561829600_kwz169C3","author":"Global Initiative for Chronic Obstructive Lung Disease (GOLD)","year":"2018"},{"issue":"9589","key":"2019110318561829600_kwz169C4","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/S0140-6736(07)61382-8","article-title":"COPD exacerbations: defining their cause and prevention","volume":"370","author":"Wedzicha","year":"2007","journal-title":"Lancet"},{"key":"2019110318561829600_kwz169C5","author":"National Heart, Lung, and Blood Institute","year":"2012"},{"issue":"2","key":"2019110318561829600_kwz169C6","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/01.NAJ.0000426688.96330.60","article-title":"COPD exacerbations","volume":"113","author":"Burt","year":"2013","journal-title":"Am J Nurs"},{"issue":"4","key":"2019110318561829600_kwz169C7","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.chest.2016.05.002","article-title":"COPD readmissions: addressing COPD in the era of value-based health care","volume":"150","author":"Shah","year":"2016","journal-title":"Chest"},{"issue":"5","key":"2019110318561829600_kwz169C8","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1164\/ajrccm.157.5.9709032","article-title":"Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease","volume":"157","author":"Seemungal","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"issue":"Spec Iss","key":"2019110318561829600_kwz169C9","first-page":"21","article-title":"Exacerbations of COPD","volume":"11","author":"Pavord","year":"2016","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2019110318561829600_kwz169C10","doi-asserted-by":"crossref","first-page":"203","DOI":"10.2147\/COPD.S3385","article-title":"Exacerbation rate, health status and mortality in COPD\u2013a review of potential interventions","volume":"4","author":"Seemungal","year":"2009","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2019110318561829600_kwz169C11","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.2147\/COPD.S139470","article-title":"Impact and prevention of severe exacerbations of COPD: a review of the evidence","volume":"12","author":"Halpin","year":"2017","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"3","key":"2019110318561829600_kwz169C12","first-page":"265","article-title":"Predicting acute exacerbations in chronic obstructive pulmonary disease","volume":"24","author":"Samp","year":"2018","journal-title":"J Manag Care Spec Pharm"},{"key":"2019110318561829600_kwz169C13","doi-asserted-by":"crossref","first-page":"g445","DOI":"10.1136\/bmj.g445","article-title":"Safety of benzodiazepines and opioids in very severe respiratory disease: national prospective study","volume":"348","author":"Ekstr\u00f6m","year":"2014","journal-title":"BMJ"},{"issue":"3","key":"2019110318561829600_kwz169C14","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1183\/13993003.01967-2015","article-title":"Incident opioid drug use and adverse respiratory outcomes among older adults with COPD","volume":"48","author":"Vozoris","year":"2016","journal-title":"Eur Respir J"},{"issue":"15","key":"2019110318561829600_kwz169C15","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1001\/jama.2016.1464","article-title":"CDC guideline for prescribing opioids for chronic pain\u2013United States, 2016","volume":"315","author":"Dowell","year":"2016","journal-title":"JAMA"},{"issue":"6","key":"2019110318561829600_kwz169C16","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1093\/bja\/aen094","article-title":"Opioids and the control of respiration","volume":"100","author":"Pattinson","year":"2008","journal-title":"Br J Anaesth"},{"issue":"5","key":"2019110318561829600_kwz169C17","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.amjsurg.2005.07.015","article-title":"Postoperative day one: a high risk period for respiratory events","volume":"190","author":"Taylor","year":"2005","journal-title":"Am J Surg"},{"issue":"1","key":"2019110318561829600_kwz169C18","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1097\/ACO.0000000000000541","article-title":"Risk factors for opioid-induced respiratory depression and failure to rescue: a review","volume":"31","author":"Gupta","year":"2018","journal-title":"Curr Opin Anaesthesiol"},{"issue":"4","key":"2019110318561829600_kwz169C19","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/phar.1223","article-title":"Cost and quality implications of opioid\u2010based postsurgical pain control using administrative claims data from a large health system: opioid\u2010related adverse events and their impact on clinical and economic outcomes","volume":"33","author":"Kessler","year":"2013","journal-title":"Pharmacotherapy"},{"issue":"7","key":"2019110318561829600_kwz169C20","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1513\/AnnalsATS.201501-034OC","article-title":"Effects of opioids on breathlessness and exercise capacity in chronic obstructive pulmonary disease. A systematic review","volume":"12","author":"Ekstr\u00f6m","year":"2015","journal-title":"Ann Am Thorac Soc"},{"key":"2019110318561829600_kwz169C21","author":"Centers for Disease Control and Prevention"},{"issue":"6","key":"2019110318561829600_kwz169C22","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1586\/17476348.2014.957186","article-title":"Do benzodiazepines contribute to respiratory problems?","volume":"8","author":"Vozoris","year":"2014","journal-title":"Expert Rev Respir Med"},{"issue":"145","key":"2019110318561829600_kwz169C23","doi-asserted-by":"crossref","first-page":"160123","DOI":"10.1183\/16000617.0123-2016","article-title":"Effectiveness and safety of concurrent beta-blockers and inhaled bronchodilators in COPD with cardiovascular comorbidities","volume":"26","author":"Corrao","year":"2017","journal-title":"Eur Respir Rev"},{"issue":"15","key":"2019110318561829600_kwz169C24","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.1002\/sim.3171","article-title":"Analysis of recurrent event data under the case-crossover design with applications to elderly falls","volume":"27","author":"Luo","year":"2008","journal-title":"Stat Med"},{"issue":"1","key":"2019110318561829600_kwz169C25","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1378\/chest.11-0024","article-title":"The validity of International Classification of Diseases, Ninth Revision, Clinical Modification diagnosis codes for identifying patients hospitalized for COPD exacerbations","volume":"141","author":"Stein","year":"2012","journal-title":"Chest"},{"issue":"2","key":"2019110318561829600_kwz169C26","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1001\/jamainternmed.2014.6512","article-title":"Tramadol use and the risk of hospitalization for hypoglycemia in patients with noncancer pain","volume":"175","author":"Fournier","year":"2015","journal-title":"JAMA Intern Med"},{"issue":"12","key":"2019110318561829600_kwz169C27","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1016\/j.clinthera.2007.12.016","article-title":"Is morphine exposure associated with acute chest syndrome in children with vaso-occlusive crisis of sickle cell disease? A 6-year case-crossover study","volume":"29","author":"Finkelstein","year":"2007","journal-title":"Clin Ther"},{"issue":"2","key":"2019110318561829600_kwz169C28","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s40263-013-0038-1","article-title":"Newly initiated opioid treatment and the risk of fall-related injuries. A nationwide, register-based, case-crossover study in Sweden","volume":"27","author":"S\u00f6derberg","year":"2013","journal-title":"CNS Drugs"},{"issue":"6","key":"2019110318561829600_kwz169C29","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1093\/aje\/kwn364","article-title":"Use of self-controlled analytical techniques to assess the association between use of prescription medications and the risk of motor vehicle crashes","volume":"169","author":"Gibson","year":"2009","journal-title":"Am J Epidemiol"},{"issue":"4","key":"2019110318561829600_kwz169C30","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1080\/15389580902995380","article-title":"Opium consumption and the risk of traffic injuries in regular users: a case-crossover study in an emergency department","volume":"10","author":"Majdzadeh","year":"2009","journal-title":"Traffic Inj Prev"},{"issue":"1","key":"2019110318561829600_kwz169C31","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1136\/ebmed-2014-110130","article-title":"Low-dose opioids should be considered for symptom relief also in advanced chronic obstructive pulmonary disease (COPD)","volume":"20","author":"Ekstr\u00f6m","year":"2015","journal-title":"Evid Based Med"},{"issue":"1","key":"2019110318561829600_kwz169C32","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1136\/ebmed-2014-110141","article-title":"Response to Ekstr\u00f6m et al. regarding low-dose opioids in advanced chronic obstructive pulmonary disease (COPD)","volume":"20","author":"Vozoris","year":"2015","journal-title":"Evid Based Med"},{"issue":"4","key":"2019110318561829600_kwz169C33","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1111\/bcp.12842","article-title":"Opioids in chronic obstructive pulmonary disease: the whole picture using all available evidence","volume":"81","author":"Currow","year":"2016","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"2019110318561829600_kwz169C34","doi-asserted-by":"crossref","first-page":"1602311","DOI":"10.1183\/13993003.02311-2016","article-title":"Incident opioid drug use and adverse respiratory outcomes among older adults with COPD","volume":"49","author":"Ekstr\u00f6m","year":"2017","journal-title":"Eur Respir J"},{"key":"2019110318561829600_kwz169C35","first-page":"CD007354","article-title":"Benzodiazepines for the relief of breathlessness in advanced malignant and non\u2010malignant diseases in adults","volume":"10","author":"Simon","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"2019110318561829600_kwz169C36","author":"US Food and Drug Administration","year":"2017"},{"issue":"6","key":"2019110318561829600_kwz169C37","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1183\/09031936.00048912","article-title":"The role of bronchodilator treatment in the prevention of exacerbations of COPD","volume":"40","author":"Wedzicha","year":"2012","journal-title":"Eur Respir J"},{"key":"2019110318561829600_kwz169C38","first-page":"CD001288","article-title":"Systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease","volume":"1","author":"Wood-Baker","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"2019110318561829600_kwz169C39","doi-asserted-by":"crossref","first-page":"g5237","DOI":"10.1136\/bmj.g5237","article-title":"Management and prevention of exacerbations of COPD","volume":"349","author":"Aaron","year":"2014","journal-title":"BMJ"},{"issue":"3","key":"2019110318561829600_kwz169C40","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1378\/chest.09-1543","article-title":"American College of Chest Physicians consensus statement on the management of dyspnea in patients with advanced lung or heart disease","volume":"137","author":"Mahler","year":"2010","journal-title":"Chest"},{"issue":"4","key":"2019110318561829600_kwz169C41","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1164\/rccm.201111-2042ST","article-title":"An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea","volume":"185","author":"Parshall","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"2019110318561829600_kwz169C42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40265-013-0162-8","article-title":"Opioids for chronic refractory breathlessness: right patient, right route?","volume":"74","author":"Currow","year":"2014","journal-title":"Drugs"},{"key":"2019110318561829600_kwz169C43","author":"Centers for Medicare & Medicaid Services","year":"2019"},{"key":"2019110318561829600_kwz169C44","author":"National Committee for Quality Assurance","year":"2017"},{"issue":"11","key":"2019110318561829600_kwz169C45","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/S1553-7250(08)34086-0","article-title":"Positive predictive value of ICD-9-CM codes to detect acute exacerbation of COPD in the emergency department","volume":"34","author":"Ginde","year":"2008","journal-title":"Jt Comm J Qual Patient Saf"},{"issue":"3","key":"2019110318561829600_kwz169C46","doi-asserted-by":"crossref","first-page":"164","DOI":"10.3109\/15412555.2010.481696","article-title":"Hospitalizations for acute exacerbations of chronic obstructive pulmonary disease: how you count matters","volume":"7","author":"Stein","year":"2010","journal-title":"COPD"},{"issue":"5","key":"2019110318561829600_kwz169C47","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1093\/ije\/dyu081","article-title":"Exchangeability in the case-crossover design","volume":"43","author":"Mittleman","year":"2014","journal-title":"Int J Epidemiol"},{"key":"2019110318561829600_kwz169C48","author":"Centers for Medicare & Medicaid Services","year":"2018"}],"container-title":["American Journal of Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/aje\/advance-article-pdf\/doi\/10.1093\/aje\/kwz169\/29310240\/kwz169.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/aje\/article-pdf\/188\/11\/1970\/30333206\/kwz169.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/aje\/article-pdf\/188\/11\/1970\/30333206\/kwz169.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,3]],"date-time":"2019-11-03T23:57:15Z","timestamp":1572825435000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/aje\/article\/188\/11\/1970\/5540805"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,30]]},"references-count":48,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2019,8,30]]},"published-print":{"date-parts":[[2019,11,1]]}},"URL":"https:\/\/doi.org\/10.1093\/aje\/kwz169","relation":{},"ISSN":["0002-9262","1476-6256"],"issn-type":[{"value":"0002-9262","type":"print"},{"value":"1476-6256","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,11]]},"published":{"date-parts":[[2019,8,30]]}}}